MetLife Investment Management’s Delek US DK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.48M | Sell |
32,829
-320
| -1% | -$11.4K | 0.01% | 1218 |
|
|
2025
Q4 | $983K | Sell |
33,149
-1,550
| -4% | -$55.3K | ﹤0.01% | 1439 |
|
|
2025
Q3 | $1.12M | Sell |
34,699
-3,179
| -8% | -$83K | 0.01% | 1374 |
|
|
2025
Q2 | $802K | Hold |
37,878
| – | – | ﹤0.01% | 1429 |
|
|
2025
Q1 | $571K | Sell |
37,878
-654
| -2% | -$11.3K | ﹤0.01% | 1663 |
|
|
2024
Q4 | $713K | Buy |
38,532
+2,311
| +6% | +$41.4K | ﹤0.01% | 1597 |
|
|
2024
Q3 | $679K | Hold |
36,221
| – | – | ﹤0.01% | 1614 |
|
|
2024
Q2 | $897K | Buy |
36,221
+3,405
| +10% | +$94.2K | 0.01% | 1402 |
|
|
2024
Q1 | $1.01M | Sell |
32,816
-1,546
| -4% | -$41.8K | 0.01% | 1295 |
|
|
2023
Q4 | $887K | Hold |
34,362
| – | – | 0.01% | 1364 |
|
|
2023
Q3 | $976K | Sell |
34,362
-743
| -2% | -$20.1K | 0.01% | 1248 |
|
|
2023
Q2 | $841K | Sell |
35,105
-1,674
| -5% | -$38K | 0.01% | 1366 |
|
|
2023
Q1 | $844K | Hold |
36,779
| – | – | 0.01% | 1316 |
|
|
2022
Q4 | $993K | Hold |
36,779
| – | – | 0.01% | 1217 |
|
|
2022
Q3 | $998K | Hold |
36,779
| – | – | 0.01% | 1192 |
|
|
2022
Q2 | $950K | Hold |
36,779
| – | – | 0.01% | 1232 |
|
|
2022
Q1 | $780K | Buy |
36,779
+13,076
| +55% | +$237K | 0.01% | 1484 |
|
|
2021
Q4 | $355K | Hold |
23,703
| – | – | ﹤0.01% | 1698 |
|
|
2021
Q3 | $426K | Hold |
23,703
| – | – | ﹤0.01% | 1614 |
|
|
2021
Q2 | $512K | Sell |
23,703
-4,274
| -15% | -$96.5K | ﹤0.01% | 1552 |
|
|
2021
Q1 | $609K | Hold |
27,977
| – | – | 0.01% | 1408 |
|
|
2020
Q4 | $450K | Hold |
27,977
| – | – | ﹤0.01% | 1536 |
|
|
2020
Q3 | $311K | Sell |
27,977
-5,309
| -16% | -$81.7K | ﹤0.01% | 1611 |
|
|
2020
Q2 | $580K | Hold |
33,286
| – | – | 0.01% | 1300 |
|
|
2020
Q1 | $525K | Hold |
33,286
| – | – | 0.01% | 1193 |
|
|
2019
Q4 | $1.12M | Hold |
33,286
| – | – | 0.01% | 1048 |
|
|
2019
Q3 | $1.21M | Sell |
33,286
-2,397
| -7% | -$88.2K | 0.01% | 978 |
|
|
2019
Q2 | $1.45M | Hold |
35,683
| – | – | 0.02% | 947 |
|
|
2019
Q1 | $1.3M | Hold |
35,683
| – | – | 0.01% | 972 |
|
|
2018
Q4 | $1.16M | Hold |
35,683
| – | – | 0.01% | 964 |
|
|
2018
Q3 | $1.51M | Buy |
+35,683
| New | +$1.76M | 0.02% | 968 |
|
|
2018
Q2 | – | Sell |
-36,076
| Closed | -$1.47M | – | 2182 |
|
|
2018
Q1 | $1.47M | Hold |
36,076
| – | – | 0.02% | 874 |
|
|
2017
Q4 | $1.26M | Buy |
+36,076
| New | +$1.06M | 0.01% | 940 |
|
Other funds holding DK
VPM
RCMNY
VCM
RRAM
MetLife Investment Management's DK Position: Q1 2026 in Review
MetLife Investment Management reduced its Delek US (DK) stake by 0.97% in Q1 2026, selling an estimated $11.4K and leaving 32,829 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #1218.
MetLife Investment Management first reported a position in DK in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.51M in Q3 2018. 277 funds tracked by Wall St. Rank hold DK as of Q1 2026.
- MetLife Investment Management held 32,829 shares of Delek US worth $1.48M as of Q1 2026.
- MetLife Investment Management sold 320 Delek US shares in Q1 2026, an estimated $11.4K.
- Delek US made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1218 holding.
- MetLife Investment Management first reported a position in Delek US in Q4 2017 and has held it in 33 quarters since.
- MetLife Investment Management's Delek US position peaked at $1.51M in Q3 2018.
- 277 funds tracked by Wall St. Rank held Delek US as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.